Local-regional recurrence (LRR) following neoadjuvant endocrine therapy: Data from ACOSOG Z1031 (Alliance), a randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor–rich stage 2 to 3 breast cancer versus chemotherapy.
- Citation:
- Ann Surg Oncol vol 27 (Suppl 1) S5
- Meeting Instance:
- SSO 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3790
- Pharmas:
- CTI BioPharma Corp
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Kelly K. Hunt Vera J. Suman Ann M. Leitch Gary Unzeitig Judy Boughey Funda Meric-Bernstam John Olson Matthew J. Ellis
- Networks:
- GA005, LAPS-MN026, LAPS-TX011, LAPS-TX035, TX041, TX190
- Study
- ACOSOG-Z1031
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: